Other
Increase (Decrease) in Accounts Receivable
Amgen Increase (Decrease) in Accounts Receivable decreased by 138.4% to -$413.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 131.6%, from $1.31B to -$413.00M. Over 3 years (FY 2021 to FY 2025), Increase (Decrease) in Accounts Receivable shows an upward trend with a 89.0% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase often signals rising sales or slower collections, while a decrease suggests improved collection efficiency or declining sales volume.
Detailed definition
Measures the net change in amounts owed to the company by customers for goods or services delivered on credit. It reflec...
Peer comparison
A fundamental working capital metric used by all companies to assess cash conversion cycles.
Metric ID:
other_increase_decrease_in_accounts_receivableHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $56.00M | $304.00M | $160.00M | $195.00M | $309.00M | $62.00M | $180.00M | $144.00M | $96.00M | $342.00M | $433.00M | -$486.00M | $342.00M | -$473.00M | $1.31B | $515.00M | $0.00 | $1.08B | -$413.00M |
| QoQ Change | — | +442.9% | -47.4% | +21.9% | +58.5% | -79.9% | +190.3% | -20.0% | -33.3% | +256.3% | +26.6% | -212.2% | +170.4% | -238.3% | +376.5% | -60.6% | -100.0% | — | -138.4% |
| YoY Change | — | — | — | — | +451.8% | -79.6% | +12.5% | -26.2% | -68.9% | +451.6% | +140.6% | -437.5% | +0.0% | -209.2% | +369.1% | — | -100.0% | +327.3% | -131.6% |
Range-$486.00M – $1.31B
CAGR+55.9%
Avg YoY Growth+50.0%
Median YoY Growth-13.1%
Increase (Decrease) in Accounts Receivable at Other Companies
Frequently Asked Questions
- What is Amgen's increase (decrease) in accounts receivable?
- Amgen (AMGN) reported increase (decrease) in accounts receivable of -$413.00M in Q1 2026.
- How has Amgen's increase (decrease) in accounts receivable changed year-over-year?
- Amgen's increase (decrease) in accounts receivable decreased by 131.6% year-over-year, from $1.31B to -$413.00M.
- What is the long-term trend for Amgen's increase (decrease) in accounts receivable?
- Over 3 years (2021 to 2025), Amgen's increase (decrease) in accounts receivable has grown at a 89.0% compound annual growth rate (CAGR), from $429.00M to $2.90B.
- What does increase (decrease) in accounts receivable mean?
- The change in the amount of money customers owe the company for past purchases.